INCI identity and material context can be reviewed without a project dossier.
For the formulation or claims lead deciding what a precedent can support
What can a finished-formulation precedent actually support?
A result becomes misleading when formula, concentration, comparator, population, duration or endpoint disappear. This page shows the evidence architecture without publishing controlled participant images or unapproved numerical claims.
Application worlds and transferability checks are shown without controlled payloads.
Current relevance, rights, market and project purpose are checked before handover.
Every future finished product requires its own safety, stability, performance and regulatory review.
Five application worlds · no universal ingredient claim
The tested product context travels with the result.
The controlled archive contains formulation and study precedents. The public site deliberately keeps participant material and numerical readouts behind a qualified review until primary-report, rights and claim checks are complete.
Healthy Aging
Context: Skin-feel, appearance and instrumental finished-formulation contexts
Boundary: Vehicle, concentration, protocol and endpoint must stay attached.
Blemish-prone Skin
Context: Rinse-off and leave-on development contexts
Boundary: No formulation result is an ingredient-level treatment claim.
Sensitive Skin
Context: Comfort-oriented finished-formulation contexts
Boundary: Population, comparator and exposure conditions govern transferability.
Hair & Scalp
Context: Fibre, shampoo and human-use questions
Boundary: These are separate evidence routes, not one universal hair claim.
Oral Care
Context: A finished toothpaste context
Boundary: The complete tested formula and protocol define what may be assessed.
A claim-safe decision route
From precedent to the next responsible test.
The useful question is not whether a historic result sounds attractive. It is what still has to be reproduced, adapted or independently substantiated for the intended product and market.
Match identity
Confirm the current AHE specification, file revision and project-relevant lot context.
Match formulation
Compare vehicle, concentration, process, pH, use pattern and intended user.
Match evidence
Review design, comparator, sample, endpoint, statistics, safety record and rights.
Define new work
Set the safety, stability, performance, regulatory and claim work required for the future product.
US
12,496,267
12,496,267
Granted United States patent · issued 16 December 2025
A defined part of the technology route is protected.
U.S. Patent No. 12,496,267, Extract of organic humified materials, is relevant to the dry peat-extract technology behind AHE. The patent record establishes granted U.S. claims; it does not turn every formulation, benefit statement or market into a patented or clinically validated claim.
Patent scope and status outside the United States require a current jurisdiction-specific review.For the person who must decide what to test next